Companies: 10,795·Total market cap: $144.5T
Merus N.V.

Merus N.V.

MRUSNASDAQHealthcare
$90.00
+$0.00(+0.00%)
Market Cap$6.8B
P/E Ratio—
52W High$97.14
52W Low$33.19
Overview
Foreign Private Issuer · Files 20-F / 6-K

Merus N.V. (MRUS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001651311 · MRUS · NASDAQ · as of Jun 8, 2026

Filing snapshot

581
Total Filings
SCHEDULE 13G/A
Latest Form
2026-02-17
Most Recent
2016
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001651311 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-04-07
Fiscal Year End
Apr 7, 2025
Accession No.
0001193125-25-074641
Primary Document
d898463d10ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001651311 · Accession 0001193125-25-074641

Latest Key Filings

6-KQuarterly Report
6-K
2019-12-31
View 6-K on SEC
8-KCurrent Report
8-K
2025-12-30Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
15-12G15-12G
15-12G
2026-01-09
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-12-30
View
25-NSE/A25-NSE/A
25-NSE/A
2025-12-30
View
8-KCurrent Report
8-K
2025-12-30
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2025-12-30
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2025-12-30
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2025-12-19
View
3Initial Statement of Beneficial Ownership
3
2025-12-18
View
S-8 POSS-8 POS
S-8 POS
2025-12-12
View
S-8 POSS-8 POS
S-8 POS
2025-12-12
View
S-8 POSS-8 POS
S-8 POS
2025-12-12
View
S-8 POSS-8 POS
S-8 POS
2025-12-12
View
POSASRPOSASR
POSASR
2025-12-12
View
8-KCurrent Report
8-K
2025-12-12
View
Showing 1–15 of 357 filingsForm 4 / 144 hidden· 581 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001651311  |  Exchange: NASDAQ · Healthcare

Merus N.V. (NASDAQ: MRUS) has submitted 581 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001651311, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Merus N.V.'s most comprehensive regulatory disclosure. The most recent Merus N.V. 10-K was filed on 2025-04-07 for fiscal year ending 2025. Historical MRUS 10-K annual reports are available from 2015 through 2025.

Investors researching Merus N.V. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
JAZZ SEC Filings →AXSM SEC Filings →CYTK SEC Filings →HALO SEC Filings →CORT SEC Filings →MTSR SEC Filings →ABVX SEC Filings →NUVL SEC Filings →
→ MRUS Financials→ MRUS Earnings→ MRUS Insider Trades

Frequently Asked Questions

MRUS SEC Filings · 8 questions

Merus N.V. (MRUS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 581 filings and access original documents at no cost. Merus N.V.'s CIK is 0001651311.

MRUS SEC filingsMerus N.V. SEC documentsfind MRUS 10-K